subcutaneous drug delivery

NVS
Biotech

Novartis inks $3.2B subcutaneous delivery deal with Alteogen

Novartis joins Biogen and GSK on the list of drugmakers to pay to access Alteogen's technology this year.
Nick Paul Taylor Sep 2, 2026 7:51am
Close-up of human eye

Viridian’s Tepezza rival racks up another ph. 3 win

May 5, 2026 8:00am
Illustration connected puzzle pieces with the acronym MA
Favicon Fierce Pharma

Halozyme catches M&A wave to snap up Surf Bio

Jan 28, 2026 2:06pm
Torley
Favicon Fierce Pharma

Halozyme CEO targets new deals as IRA uncertainty subsides

Oct 14, 2025 9:40am
puzzle pieces merger and acquisition business concept
Favicon Fierce Pharma

Halozyme buys Elektrofi for up to $900M

Oct 1, 2025 2:36pm
pivot change turnaround direction walk away

Lundbeck ends subcutaneous migraine cohort after futility review

Apr 1, 2025 5:00am